A Novel Anti-HER2 Antibody-Drug Conjugate XMT-1522 for HER2-Positive Breast and Gastric Cancers Resistant to Trastuzumab Emtansine

Huom! Embargollinen tiedosto,
avautuu julkiseksi: 10.07.2020

Le Joncour, Vadim

Martins, Ana

Puhka, Maija

Isola, Jorma

Salmikangas, Marko

Laakkonen, Pirjo

Joensuu, Heikki

Barok, Mark

2019

Molecular Cancer Therapeutics 18 10
1721-1730
Lääketieteen ja terveysteknologian tiedekunta - Faculty of Medicine and Health Technology

This publication is copyrighted. You may download, display and print it for Your own personal use. Commercial use is prohibited.